• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number T177
Device Problems Device Alarm System (1012); Premature Discharge of Battery (1057)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/24/2014
Event Type  Injury  
Event Description
Boston scientific received information that this implantable cardioverter defibrillator (icd) is suspected to have premature battery depletion (pbd).Last routine follow up in january of this year showed device longevity at middle of life (mol) status.Approximately one month later, the device exhibited tones as the device was at elective replacement indicator (eri).Normal measurements were observed on the electrodes.Device was then explanted and was sent for analysis.This icd is out of service.No additional adverse patient effects were reported.
 
Event Description
--.
 
Manufacturer Narrative
The product is expected to be returned for analysis.This report will be updated upon return and completion of analysis.
 
Manufacturer Narrative
(b)(4).Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.During initial investigation, it was reported that the device did not have an elective replacement indicator (eri) timestamp and that end of life (eol) was declared while implanted.Memory analysis found that eol was declared in result of a long charge time.The cause of the long charge time was not determined.Further detailed analysis found no functional irregularities in device operation.All therapy, sensing, and pacing was available at the time of explant.Laboratory analysis confirmed the reported clinical observation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITALITY 2
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
sharon zurn
4100 hamline ave. n
st. paul, MN 55112
6515824786
MDR Report Key3790197
MDR Text Key4440218
Report Number2124215-2014-06048
Device Sequence Number1
Product Code KRG
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/04/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/05/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/23/2009
Device Model NumberT177
Other Device ID NumberVITALITY 2 VR EL
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/20/2014
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received06/04/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/25/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
T177; 0175
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
-
-